Offers

Carna’s Profiling Services Discount Campaign!

Carna’s Next-Gen Mobility Shift Assay (MSA) System supporting kinase drug discovery is now operational with scientific and budget friendly benefits!

The unique, Next-Gen MSA Detection system, established using Carnas in-house kinase focused expertise and the Sciex BioPhaseTM 8800 Capillary Electrophoresis System has been integrated with an automated arm to increase throughput.
To celebrate this remarkable achievement, we’re excited to present you with two exclusive offers!
 

Offer 1

30% Discount for reciprocal biochemical or cellular studies!

Step 1: Evaluate compounds using either our biochemical or cell-based assay services.
Step 2: Receive 30% discount on your second order using same compounds in the reciprocal service.

Offer 2

Zero cost follow-up IC50 determinations!

Step 1: Evaluate compounds in our biochemical % inhibition service.
Step 2: Receive Zero Cost IC50 follow up studies using same compounds.

Study report comes with Carna’s original Kinome Map (sample image on the right), on which your data is graphically displayed for easy assessment of specificity and activity. For more details, please contact us at info@kinaselogistics.com.

Offer Conditions
1. With a % inhibition order against 50 or more kinase targets, receive complimentary follow-up IC50 determinations against up to 4 kinase targets* (for each screened compound).
2. With a % inhibition order against 100 or more kinase targets, receive complimentary follow-up IC50 determinations against up to 8 kinase targets* (for each screened compound).


Valid now through November 27, 2024.
Don’t miss these one-time opportunities!

Further news

  • Next-generation Mobility Shift Assay Detection System! General

    Next-generation Mobility Shift Assay Detection System!

    We have great News for you: MSA is still accessible to your drug discovery research!
     

    Read more
  • Biotinylated Kinases General

    Biotinylated Kinases

    We’ve new products for you: biologically biotinylated human Kinases from Carna Biosciences.

    Read more
  • New Cellular CDK Assay Panel Launched and Special Offers from Carna Offers

    New Cellular CDK Assay Panel Launched and Special Offers from Carna

    We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.

    Read more
Contact us